Analytical Data
-
基因名
Ferritin heavy chain/FTH1
- Application
-
别名
Cysteine-rich protein TTG-1LIM domain only protein 1 ;LMO-1T-cell translocation protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P02794
-
表达区间
2-183aa
-
分子量
48.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Ferritin heavy chain (FTH1) is a crucial protein involved in iron storage and homeostasis within the body. It plays a significant role in many physiological processes, including cellular iron regulation, antioxidant defense, and modulation of immune responses. Abnormalities in FTH1 expression and function are associated with various diseases, such as neurodegenerative disorders, cancer, and cardiovascular diseases. With the increasing prevalence of iron-related disorders, understanding the mechanisms underlying FTH1 functionality has become a pertinent area of research. Recombinant FTH1 proteins are being developed for various applications, including therapeutic interventions and diagnostic tools. These recombinant proteins can be used to study the structure-function relationships of FTH1, investigate its role in iron metabolism, and explore potential therapeutic targets for disease treatment. Moreover, the generation of FTH1 recombinant proteins allows for the exploration of their properties in vitro and in vivo, providing insights into their clinical relevance. As research advances, recombinant FTH1 may offer novel approaches for managing conditions related to iron dysregulation and present opportunities to enhance our understanding of cellular iron dynamics.
